Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-021857
Filing Date
2016-06-06
Accepted
2016-06-06 20:48:53
Documents
1
Period of Report
2016-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9972
  Complete submission text file 0000899243-16-021857.txt   11619
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Issuer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BROOKSIDE CAPITAL, LLC JOHN HANCOCK TOWER, 200 CLARENDON ST BOSTON MA 02116
Business Address
Koppel Adam (Reporting) CIK: 0001578965 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19311 | Film No.: 161699797